|
|
| Improving Resilience of Post-Pandemic Biopharma Supply Chains | Improving supply chain resilience is critical for Biopharma. One lesson learned from the pandemic is the need for new models and approaches to managing supply chains. Download our white paper to learn more about how a value chain model mitigates risk, the four critical ingredients to supply chain resilience, and why preparations based on "the last war" aren't enough. |
|
|
|
|
By BioPhorum | Aseptic process simulation (APS) plays a critical role in demonstrating that the processes, equipment, and materials involved in sterile manufacturing work in synergy to maintain sterility. Applying existing APS guidelines to cell and gene therapies/ATMPs can be challenging, so BioPhorum proposes a best practice approach in alignment with regulatory guidance. |
|
|
|
|
|
|
|
| How To Best Optimize CD4 T Cells Expansion | Application Note | By Silvia Tejerina Vargas, Vincent Dufey, Aurelie Tacheny, and Francoise De Longueville, Eppendorf SE | Learn how stirred-tank bioreactors can be used to efficiently expand T cells from different donors. |
|
|
| Leverage Automated Workflows To Enable Complex Organoid Assays | Poster | By Oksana Sirenko, Zhisong Tong, Krishna Macha, and Angeline Lim, Danaher Life Sciences | Learn about automated methods that utilize an integrated workcell, providing automated cell plating, culture monitoring, media exchange, and high-content imaging. |
|
|
|
| Immunohistochemistry (IHC) Handbook | e-book | bio-techne | Learn more about immunocytochemistry, immunohistochemistry workflow, visual workflow, troubleshooting, and basic buffer and reagent recipes. |
|
|
|
|
|
| Building The Complete Solution For Viral Vector Production | Webinar | Applied Biosystems by Thermo Fisher Scientific, qPCR | AAV is becoming the go-to biological delivery method for gene therapy breakthroughs. Learn how to scale and accelerate your viral vector production from research to commercialization. |
|
|
|
|
| Webinar: Upstream To Downstream: A Comprehensive Approach To AAV Production | Paula Decaria and Chiu Lau-Barre of Thermo Fisher Scientific will share strategies to meet the rapid pace of the industry. Gain insights on the challenges and considerations involved in scaling up AAV manufacturing processes, facilitating AAV production with high titers using single-use bioreactors at 50 L to 500 L to 1,000 L scales and techniques for enhancing recovery and purity in downstream processing. |
|
|
|
|
|
|
|
|
|
|
|
|
| As additional mRNA-based cancer immunotherapies vaccines enter clinical development, operational and supply chain challenges must be addressed to reduce turnaround times and COGS. Join Cell & Gene Live on December 5 for a breakdown of ways to address uncoordinated and inefficient processes to promote greater stability and immunogenicity. This digital event is free to attend thanks to the support of Thermo Fisher Scientific. Register Now |
|
|
LIFE SCIENCE LEADER MAGAZINE |
|
|
|
Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business. |
|
|
| Connect With Cell & Gene: |
|
|
|
